Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma.
Lin YH, Wang H, Fiore A, Förster M, Tung LT, Belle JI, Robert F, Pelletier J, Langlais D, Nijnik A.
Lin YH, et al. Among authors: nijnik a.
J Cell Mol Med. 2021 Jul;25(14):7089-7094. doi: 10.1111/jcmm.16554. Epub 2021 Jun 11.
J Cell Mol Med. 2021.
PMID: 34114734
Free PMC article.